Followers | 390 |
Posts | 10169 |
Boards Moderated | 9 |
Alias Born | 05/25/2003 |
Sunday, April 05, 2020 11:32:20 AM
There were multiple boards open for various tickers for Ligand. iHub allows only one board per publicly traded company. It doesn't matter how many derivative tickers there are - only one open board for posting. Other boards can exist for purposes of seeing quotes in lists, etc., But they are closed to posting.
We are swapping the name and ticker of this and one of the Rights boards so this board has the Listed (NASDAQ) ticker and name. This is the board that was left open because it has the most posts and moderators. The listed ticker (LGND) board didn't have any moderators. So, we will swap the names and tickers so this has the listed name and ticker.
This board is for discussion of Ligand, its subsidiaries and all of its trading instruments. That includes but is not limited to discussion of differences, arbitrage opportunities and relative values and prospects of its different trading instruments,
Many are unhappy with this. Sorry, but that's how it is. The other boards should not have been opened for posting. All we are doing is fixing that. It happens all the time.
Sorry for the confusion and inconvenience, but it is not open for debate.
Finally, please keep your posts on topic - about the stock, company and its principals. Or, expect to see your posts removed and posting privileges restricted.
For your convenience:
http://ih.advfn.com/p.php?pid=pf_summary&p=5&u=ih_21785
http://ih.advfn.com/p.php?pid=squote&symbol=LGND Ligand Pharmaceuticals Inc
http://ih.advfn.com/p.php?pid=squote&symbol=LGNZZ Ligand Pharmaceuticals Inc.Trust Beta Contingent Value Rights
http://ih.advfn.com/p.php?pid=squote&symbol=LGNDZ Ligand Pharmaceuticals Inc. Roche Contingent Value Rights
http://ih.advfn.com/p.php?pid=squote&symbol=LGNYZ Ligand Pharmaceuticals Inc. General Contingent Value Rights
http://ih.advfn.com/p.php?pid=squote&symbol=LGNXZ Ligand Pharmaceuticals Inc. Glucagon Contingent Value Rights
Recent LGND News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/26/2024 12:54:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/24/2024 11:41:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/24/2024 11:41:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/23/2024 09:30:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/23/2024 09:27:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/31/2024 01:00:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/31/2024 12:56:18 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/28/2024 08:39:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 12:15:37 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2024 10:05:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 09:21:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 09:52:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/09/2024 09:16:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:30:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 09:15:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 09:10:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 08:02:22 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/09/2024 08:52:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 11:38:30 AM
- Lifecore Biomedical Announces Cooperation Agreement with 22NW • GlobeNewswire Inc. • 07/01/2024 12:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/03/2024 08:03:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:03:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2024 12:00:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 11:59:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/17/2024 09:45:03 PM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM